Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder

被引：3
|
作者：
Kawahara, Takashi [1 ]
Nishiyama, Hiroyuki [1 ]
Yamamoto, Shingo [1 ]
Kamoto, Toshiyuki [1 ]
Ogawa, Osamu [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Urol, Sakyo Ku, Kyoto 6068507, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2006年 / 13卷 / 09期
关键词：
bladder tumor; irinotecan; small cell carcinoma;
D O I：
10.1111/j.1442-2042.2006.01521.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A 73-year-old man with primary small-cell carcinoma of the bladder was treated by radical cystectomy with neoadjuvant chemotherapy. Pathological complete remission was achieved by combination chemotherapy composed of cisplatin, etoposide and irinotecan. The patient is free of disease 19 months after surgery.
引用
收藏
页码：1251 / 1253
页数：3
相关论文
共 50 条
  • [41] Complete remission with intraperitoneal cisplatin followed by prolonged oral etoposide in a stage IIIc primary leiomyosarcoma of the fallopian tube patient
    Kobayashi, Yoichi
    Tozawa, Akiko
    Okuma, Yoshiaki
    Kiguchi, Kazushige
    Ishizuka, Bunpei
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (04) : 894 - 897
  • [42] SMALL-CELL CARCINOMA OF PROSTATE - TRANSIENT COMPLETE REMISSION WITH CHEMOTHERAPY
    HINDSON, DA
    KNIGHT, LL
    OCKER, JM
    UROLOGY, 1985, 26 (02) : 182 - 184
  • [43] Irinotecan (CPT-11) combined with cisplatin for small cell carcinoma of the nasal cavity
    Hakuba, N
    Hyodo, M
    Yokoi, T
    Sato, H
    AURIS NASUS LARYNX, 2006, 33 (01) : 67 - 70
  • [44] Small Cell Carcinoma of the Tonsil Treated with Irinotecan and Cisplatin: A Case Report and Literature Review
    Segawa, Yuichi
    Nakashima, Torahiko
    Shiratsuchi, Hideki
    Tanaka, Risa
    Mitsugi, Kenji
    Komune, Shizuo
    CASE REPORTS IN ONCOLOGY, 2011, 4 (03): : 587 - 591
  • [45] Primary small cell carcinoma of the bladder. Commentary
    Benizri, E
    PROGRES EN UROLOGIE, 1999, 9 (02): : 259 - 260
  • [46] A Case of Primary Small-Cell Carcinoma of the Bladder
    Ono, Ashita
    Hirasawa, Yosuke
    Yamashina, Mitsumasa
    Kaburagi, Naoto
    Mima, Takashi
    Sugihara, Toru
    Hamada, Riu
    Gondo, Tatsuo
    Ohori, Makoto
    Nagao, Toshitaka
    Ohno, Yoshio
    CASE REPORTS IN ONCOLOGY, 2016, 9 (03): : 574 - 579
  • [47] CISPLATIN AND ETOPOSIDE COMBINATION IN ADVANCED NON-SMALL CELL-CARCINOMA OF THE LUNG
    ROSSO, R
    SERTOLI, MR
    CANOBBIO, L
    BREMA, F
    ARDIZZONI, A
    SERRANO, S
    CHEMIOTERAPIA, 1983, 2 (03): : 166 - 168
  • [48] Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma
    Glisson, BS
    Kurie, JM
    Perez-Soler, R
    Fox, NJ
    Murphy, WK
    Fossella, FV
    Lee, JS
    Ross, MB
    Nyberg, DA
    Pisters, KMW
    Shin, DM
    Hong, WK
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2309 - 2315
  • [49] Primary pure small cell carcinoma of the urinary bladder that responded to carboplatin plus etoposide: a case report and review of the literature
    Kaya, A. O.
    Coskun, U.
    Yildiz, R.
    Gonul, I. I.
    Karagulle, K.
    Yaman, E.
    Ozturk, B.
    JOURNAL OF BUON, 2009, 14 (04): : 703 - 706
  • [50] E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
    Owonikoko, Taofeek K.
    Aisner, Joseph
    Wang, Xin Victoria
    Dahlberg, Suzanne E.
    Rubin, Eric H.
    Ramalingam, Suresh S.
    Gounder, Murugesan
    Rausch, Paul Gregory
    Axelrod, Rita S.
    Schiller, Joan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 171 - 180
12345